Student Poster

(2-001) Short-term continuous glucose monitoring and its impact on pharmacist-led diabetes medication management and blood glucose levels

(2-002) A cross-sectional survey of Alabama community pharmacist’s intentions and perceived barriers regarding fentanyl test strip provision.

(2-003) Assessment of Efficacy and Adverse Reactions in High-Dose Diltiazem Infusions for Atrial Fibrillation

(2-004) Comparing Prescription Drug Monitoring Program Perceptions and Usage Between Medical and Pharmacy Professionals: Impact of an Interdisciplinary Workshop

(2-005) Evaluation of Adverse Event Reporting of Sotagliflozin to the U.S. Food and Drug Administration

(2-006) Evaluation of Appropriate Oral Anticoagulation Use in Patients with Atrial Fibrillation

(2-007) Assessment of Alabama Prescribers’ Perceptions of Pharmacogenomics

(2-008) Resident Perceptions of Migraine Management and Interventions to Improve Care

(2-009) Evaluation of Time to Clevidipine Discontinuation When Utilizing Various Oral Antihypertensive Agents in Patients Presenting with Hemorrhagic Stroke

(2-010) Effects of Diabetes Camps/Conferences on Self-reported Perceived Stigma and Discrimination in Youth with Type 1 Diabetes

(2-011) Retrospective Review of Treatment Patterns for Hyperkalemia Management in a Community Hospital Setting

(2-012) Development of the Medication Education for Dementia Support (MEDS) Toolkit for Community Pharmacy Collaboration with Home Health

(2-013) National survey assessing the public’s perceptions of amyloid-targeting drugs for Alzheimer’s Disease

(2-014) Agreement between Vancomycin Area Under the Curve (AUC) Estimates with Pre-Steady State versus Steady State Concentrations Using Bayesian Modeling

(2-015) Clinical Cure Rates of Gram Negative Bloodstream Infections Treated with Beta-Lactam Antibiotics in Obese Patients

(2-016) Antibiotic Prescribing Patterns in Patients with Penicillin Allergies: A Comparison Before and After Deactivation of the Cross-Reactivity Pop-Up Warning

(2-017) Three ERBB4-Dependent Human Melanoma Cell Lines Are Also Dependent on ERBB2

(2-018) Healthcare Providers’ Perceptions Regarding Ease of Using the Prescription Drug Monitoring Program (PDMP) Before and After an Interdisciplinary Workshop in Alabama

(2-019) Influential Factors Associated with Fentanyl Test Strip Provision by Alabama Community Pharmacists: a Cross-Sectional Survey

(2-020) Efficacy of an In-house Pharmacist-Led Single Level Vancomycin Area Under the Curve Therapeutic Drug Monitoring Service in a Pediatric Hospital Setting

(2-021) Expanding Pharmacogenomics in the Community Pharmacy Setting: Alabama Pharmacists’ Thoughts and Perceptions

(2-022) Exploring student identity formation through the use of technology: Let’s jam!

(2-023) Female First and Senior Authorship in Pharmacy Publishing

(2-024) Assessment of psychiatric disorders associated with elevated blood pressure and hypertension diagnosis

(2-025) Don’t Sleep on It: Exploring the Link Between Sleep Agents and Mood Disorders—A Prescription Pattern Analysis

(2-026) Health Markers of Non-communicable Diseases: a Cross-Cultural Comparison of the Maldives and Alabama

(2-027) Prevalence of Antibiotic Resistance in Initial Wound Culture Among Patients Admitted to the Burn Intensive Care Unit

(2-028) Improving Pneumococcal Vaccine Rates in Pediatric Liver Transplant Patients

(2-029) Assessing the Outcomes of the Implementation of Lipid Screenings During Pharmacist-Led Medicare Annual Wellness Visits (MAWVs) for Statin Treated Patients

(2-030) Functional Characterization of An Investigational Corrector Targeting the First Nucleotide-Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator

(2-031) Retrospective Analysis of Oral Care Agent Use in a Rehabilitation Center

(2-032) Evaluation of Pharmacy Personnel Regarding Preparedness During Electronic System Downtime

(2-033) Evaluating the usage and titration of glucagon-like peptide-1 receptor agonists in patients with uncontrolled type 2 diabetes mellitus

(2-034) Safety and Efficacy of Hydrocortisone Discontinuation Strategies in Septic Shock

(2-035) Assessing the Impact of Naloxone Administration Training in Transitional Living Facilities

(2-036) Evaluating trends in suicide deaths by drug poisoning in U.S. children and adolescents (ages 5-19) in 2002-2022 using Centers for Disease Control and Prevention data

(2-037) Evaluation of transferring patient immunization profiles between southeastern states

(2-038) Evaluation of Delay in Lumbar Puncture due to Venous Thromboembolism Prophylaxis in Neurology Population

(2-039) Review of Neuromodulation Devices for Prevention and Acute Treatment of Migraine and Headache Disorders

(2-040) The Use of Antidepressants, Stimulants, and Anxiety Medications in Samford McWhorter School of Pharmacy Students

(2-042) Error Reporting Perceptions and Behaviors by Arizona Pharmacists

(2-043) Social Predictors of Ability to Perform Daily Activities Among United States Adults with Heart Disease or Cardiometabolic Risk Factors

(2-044) Prevalence and Predictors of Nonmedical or Polydrug Stimulant Misuse Among Past-Year Users of Prescribed Stimulants

(2-045) Geographic and Social Predictors of Up-To-Date Colorectal Cancer Screening in U.S. Adults Aged 45 to 75 Years

(2-046) Association of Social Determinants of Health with Up-to-Date Cervical Cancer Screening Status

(2-047) Association of Racial Awareness and Perceived Discrimination with COVID-19 Vaccination in U.S. Hispanic Adults

(2-048) Predictors of Inadequate Emotional Support Among U.S. Adults Living with Cancer

(2-049) Early History of Illegal Psychoactive Substance Use and Later-Life Dysfunction in Cognition or Communication in U.S. Adults Aged 35 Years or Older

(2-050) National Organization for Rare Disorders’ State Resource Center: 600+ Free or Low-Cost Programs and Services for People Impacted by Rare Diseases

(2-051) Association of Perceived Risks of Health Behaviors with Problematic Substance Use: Raising Awareness of Health Education Opportunities

(2-052) Computational Screening for ALKBH7 Inhibitors for the Treatment of Brain Cancer

(2-053) Linking Chronic Diseases with Negative Social Determinants of Health: Barriers to Effective Medication Management

(2-054) Racial Intersectionality and Deaths of Despair: Implications for the Practice of Pharmacy

(2-055) Social Determinants of Health Predictors of Heavy Alcohol Use with Prescription Opioids, Tranquilizers, Sedatives, or Stimulants

(2-056) Pharmacy student perceptions of a virtual curriculum on providing care to individuals with intellectual and developmental disabilities

(2-057) Evaluation of Eravacycline- or Tigecycline-Containing Triple Therapy Versus a Clinical Acinetobacter baumannii Strain in Time Kill Analysis

(2-058) Association Between Healthcare Access Indicators and Social Determinants of Health (SDOH) and COVID-19 Vaccination Uptake Among US Black and Hispanic adults

(2-060) Misuse of Prescribed Medications for Approved Versus Non-Approved Indications: Predictors and Implications for Ambulatory Care

(2-061) Factors Influencing Self-Reported Health Status Among United States Adults with Arthritis

(2-062) Evaluating Diabetic Patient Adherence Amidst the Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Shortage

(2-063) Evaluating the impact of BioFire Blood Culture Identification 2 (BCID2) result reporting on time to targeted antimicrobial therapy

(2-064) Geographical Growth Trends Amongst Patients Living with Alpha-gal Syndrome

(2-065) Identifying Preventable and Non-preventable Prescription Callbacks for Clarification at an Academic Medical Center Emergency Department from 2015-2024

(2-066) Analysis of the Impact of Decentralizing Pharmacists on the Standard of Patient Care at Mountain Vista Medical Center

(2-067) Factors Influencing Posaconazole Concentrations in Hospitalized Patients Receiving Delayed Release Tablets

(2-068) Association between pain intensity and health service utilization (emergency room visits, inpatient discharges, office visits, outpatient visits) among adults with pain in the United States.

(2-069) Analysis of Responses from Artificial Intelligence Programs to Medication-Related Questions Derived from Critical Care Guidelines

(2-070) Evaluating the accuracy of pharmaceutical calculation solutions produced by artificial intelligence

(2-071) UA Pharmacy Interns Insights: Exploring Job Satisfaction and Factors Affecting Student Pharmacists

(2-072) Systematic Review of Psychedelics in Mental Health Disorders

(2-073) Exploring Professional, Patient, and Student Perceptions of Innovative Pharmacist Roles in Non-Traditional Settings

(2-074) Student-Led Pharmacy Technician Certification Review

(2-075) Prevalence of Renal Dysfunction and Potential Modifiable Risk Factors for Disease Progression in the Population of Northwest Nicaragua

(2-076) Assessing the Impact of a Urinalysis with Reflex to Urine Culture Order on Diagnostic Stewardship in a Pediatric Emergency Department

(2-077) Assessing the Utilization of Diagnostic Testing in Pediatric Urinary Tract Infections in a Pediatric General Clinic

(2-078) Impact of an Escape Room Simulation on Pharmacy Student Knowledge and Confidence in Pain Management and Opioid Stewardship

(2-079) Impacts of Student-Centered Learning in a Pharmaceutical Calculations Course

(2-080) Characterizing Empiric Antimicrobial Selection and Duration in Different Clinic Settings for the Treatment of Pediatric Urinary Tract Infections

(2-081) Does Weight Stigma Impact Empiric Antimicrobial Selection for Treatment of Pediatric Community Acquired Pneumonia (CAP) within the Emergency Department (ED)?

(2-082) Evaluation of Clopidogrel Initiation and Monitoring in the Pediatric Population

(2-083) Exploring the Effects of Mounjaro®, a Dual GLP and GLP-1 Receptor Agonist, on Lipoprotein (a) Levels in Patients with Type 2 Diabetes

(2-085) Spanish Diabetes Group Education Sessions in a Medically Underserved Community

(2-086) ASHP Council on Pharmacy Practice; a Student’s Perspective

(2-087) Comparison of Basal Insulins in Type 2 Diabetes Mellitus with Concomitant Severe Chronic Kidney Disease or End Stage Renal Disease

(2-088) An Assessment of Acute Kidney Injury Rates in Trauma Patients: A Retrospective Chart Review

(2-089) Evaluation of Peripheral Versus Central Line Initiation of Vasopressors at a Community Hospital

(2-090) Medicinal Chemistry-Driven Discovery of Small Molecules Active Against Parasitic Infections

(2-091) Population Pharmacokinetics of Cobicistat in Pregnant and Postpartum Women with HIV

(2-092) Combination Sodium-Glucose Cotransporter-2 Inhibitors with Glucagon-Like Peptide-1 Receptor Agonists in Veterans with Type 2 Diabetes on Major Cardiovascular Events and Heart Failure

(2-093) Inpatient Management of Sickle Cell Crisis in a Community Hosptial

(2-094) Countermeasures for Space Radiation: An Umbrella Review of Antioxidants

(2-095) Code ACS Simulation in Emergency Medicine: Enhancing Student Learning Through Faculty-Student Co-Creation

(2-096) Impact of Pharmacists’ Interventions on Patient’s Length of Stay: A Systematic Review

(2-098) Incidence of Hypersensitivity Reactions in Breast Cancer Patients After Discontinuing Dexamethasone with the Fourth Dose in Weekly Paclitaxel

(2-099) Evaluating Hyperkalemia in Transgender Adolescents Using Spironolactone: A Retrospective Chart Review Study

(2-100) Next-Gen HIV Treatment: The Financial Stability and Clinical Success of Long-Acting Antiretrovirals

(2-101) Mental health impacts of heat and climate events on residents of Bayview-Hunters Point: a qualitative interview study.

(2-102) Outcomes of a Pharmacist Managed Post-Hematopoietic Stem Cell Transplantation Immunization Clinic at a Comprehensive Cancer Center

(2-103) Perceptions of Barriers to Naloxone Dispensing in Orange County Pharmacies

(2-104) Accessibility of Over-the-Counter Emergency Contraception within different areas in Orange County

(2-105) Systematic Review of Safety and Efficacy of Glucagon-like Peptide-1 Receptor Agonists in Liver Transplant Recipients with Diabetes

(2-106) Population Pharmacokinetics of Ritonavir in Pregnancy and Postpartum Women with HIV

(2-107) Model-Predicted Pharmacokinetic Exposure Analysis of Amodiaquine in Pediatric Populations Across African Countries

(2-108) Medicare Drug Price Negotiation: The Complexities of Choosing Therapeutic Alternatives and Developing an Initial Offer

(2-110) Differential Anticoagulation Effects From Warfarin Therapy

(2-111) The Impact of Risperidone-Induced Weight Gain on Different Patient Phenotypes

(2-112) Effect of tenofovir on tissue reservoirs in postmortem samples from people with human immunodeficiency virus (HIV) on antiretroviral therapy (ART)

(2-113) Predictors of Ceftriaxone and Carbapenem Use Among Hospitalized Patients in Quetzaltenango, Guatemala: An ARCH Study

(2-114) Monitoring of Liver Fibrosis by Noninvasive Measures in Chronic Hepatitis B Patients Receiving Long-term Tenofovir—based Treatment

(2-115) Additional Evidence for an Explanation of Why Bioavailability for Alternate Administration Routes of Certain Drugs May Be Greater than for Intravenous Administration

(2-116) Clinical effect of preemptive pharmacogenomic testing of CYP3A5 on transplant patients treated with TAC at a research hospital

(2-117) Clinical Outcomes of TPMT and NUDT15 Pharmacogenetic Testing in Azathioprine Therapy at UCSF Health

(2-118) Drug-Drug Interaction Between Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine in Pregnant Women During Malaria Chemoprevention

(2-119) Investigating Care Coordination Models Across Inpatient Pharmacy Specialties

(2-120) Model-Informed Tenofovir Dose Adjustments in Pediatric Patients: A Pharmacokinetic Approach to Achieve Optimal Drug Exposure

(2-121) Pharmacokinetic-Pharmacodynamic Driven Investigations of the Mechanism of Sirolimus to Decrease Human Immunodeficiency Virus Reservoir

(2-122) The Impact of As Needed Anticholinergic Medication Use in Older Adults on Anticholinergic Burden During Hospitalization

(2-123) Emtricitabine Exposure on Tissue Reservoirs in Postmortem Samples from People with Human Immunodeficiency Virus on Antiretroviral Agent

(2-124) Impact of Cirrhosis on Severity and Outcome of Staphylococcus aureus Bacteremia

(2-126) Trough-based vs AUC:MIC based Monitoring of Vancomycin: Impact on Nephrotoxicity and Efficacy at PIH Health Good Samaritan Hospital

(2-127) Real-World Implications of CABENUVA in a HIV-1 Treatment Setting: An Observational Study

(2-128) Hypertonic Saline for Traumatic Brain Injury or Stroke: A Retrospective Chart Review

(2-129) Effects of Poppi Soda on Human Gut Microbiota

(2-130) The Impact of Glucuronolactone on Cardiovascular Parameters in Energy Drinks

(2-131) Evaluating the Effects of Enhanced External Counterpulsation on Symptoms of Long COVID: a Systematic Review

(2-132) Impact of Granola Formulated with Unrefined Sugar Compared to Other Leading Granola Brands on Blood Glucose

(2-133) Impact of Nelumbo nucifera in Improving Sleep Quality: A Randomized, Double-blind, Placebo-controlled Trial

(2-134) Exploring the Potential Application of Cinnamon for UV Irradiation-Induced Skin Damage

(2-135) Statin Prescribing Practices for Veterans with HIV at Single-Center Veterans Affairs Health Care System

(2-136) Exploring the Acute Hemodynamic Effects of Normatec 3 Therapy

(2-137) Antiretroviral Medication Errors Among Veterans with HIV Hospitalized at a Veteran Affairs Health Care System

(2-138) The Use of Cinnamon Extract in Cancer Therapy through Modulating the PD-L1/PD-1 Pathway

(2-139) Exploring Homeopathy's Role in Palliative Care for Cancer Patients

(2-140) An Evaluation of Institutional Compliance to an Acute Hematogenous Osteomyelitis Algorithm at a Pediatric Hospital

(2-141) Assessing the Correlation Between Surrogate Endpoints and Clinical Benefit in Oncology Accelerated Approvals: A Comparative Analysis

(2-143) Tolerability Of Sodium Glucose Cotransporter 2 Inhibitors in Left Ventricular Assist Device Patients

(2-144) Antibiotic Stewardship in Surgical Prophylaxis: A Retrospective Medication Use Evaluation

(2-145) False-Positive Amphetamine Urine Toxicology Results in Patients Taking Labetalol: Case Report

(2-146) Flipping Out? Perceived Stress Levels and Student Perceptions of Flipped Classroom Models at USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences

(2-147) Prevalence of Potential Delayed Hepatotoxicity in Cystic Fibrosis Patients on Elexacaftor/Tezacaftor/Ivacaftor

(2-148) Real-World Patient Profiles, Treatment Patterns, and Outcomes in a Diverse Population with Multiple Myeloma

(2-149) Efficacy of Pre-Class Asynchronous Recordings on Student Performance in Flipped Classroom Settings

(2-150) Omadacycline Use in Mycobacterioides abcessus Peritonitis; a Case Report

(2-151) Evaluation of Extended Release Versus Immediate Release Dosage Form Errors at a Community Hospital

(2-152) Accuracy and Reproducibility of ChatGPT Responses to Real-World Drug Information Questions

(2-153) Advances in Cardiovascular Pharmacogenetics: From Risk Prediction to Therapeutic Optimization

(2-154) Implementing Pharmacy-Patient Care Processes: Comparison Pre- and Post-Implementation of Virtual-Based Simulations

(2-155) Approval Rates for Prior Authorizations of Commonly Prescribed Medications in a Patient-Centered Medical Home

(2-156) The Impact of Physician’s Experience and Pharmacist’s Communication Method on Accepting Recommendations for Potentially Inappropriate Medications in a Patient-Centered Medical Home

(2-157) Time Spent on Prior Authorizations for Commonly Prescribed Medications in a Patient-Centered Medical Home

(2-158) Rates of Potentially Inappropriate Medication Prescribing for Resident and Attending Physicians in a Patient-Centered Medical Home.

(2-159) Evaluation of the Top 20 Ingredients in Sexual and Muscle Enhancement Dietary Supplements: Promoting Counseling for Safe Utilization

(2-160) Determining Human Papillomavirus Vaccine Knowledge, Education, and Practices among Pharmacy Students and Faculty: A Qualitative Initiative

(2-161) Evaluation of the relationship between the classification system of outpatient drugs and their utilization across the healthcare landscape.

(2-162) Flushing Out the Cause: Anticholinergic Toxicity from Atropine Eye Drops

(2-163) Evaluating Opportunities and Use of Aprepitant in a Community Health System

(2-164) Retrospective review of albumin usage at a level-one trauma center and safety-net hospital

(2-165) Ertapenem Induced Neutropenia, a Rare Adverse Effect and Literature Review

(2-166) Impact of Obesogen Exposure on Trisomy 21

(2-167) Pharmacokinetics of Ceftriaxone in Adult Patients Weighing 80kg or More

(2-168) Analysis of a Systematic Program to Transition Patients on Warfarin to Direct Oral Anticoagulants

(2-169) Dehydrating Dilemma: A Case of Neonatal Diabetes Insipidus

(2-170) Assessment of Laboratory Monitoring Practices for Outpatient Prescription Medications in Children with Medical Complexity

(2-171) Adherence to Criteria for Use for Intravenous Acetaminophen following Implementation of a System-Wide Formulary

(2-172) Turmeric - Warfarin Interaction Resulting in Supratherapeutic INR, Bleeding, and Hospitalization

(2-173) Pharmacy Intern Derived Flu Immunization Workflow to Increase Efficiency

(2-174) Medication Use Evaluation of RiaSTAP in a Teaching Hospital

(2-175) Impact on Patient Care through a Pharmacy Intern Led Psychiatric Medication Education Group

(2-176) Use of psychotropic medication for pediatric patients with diabetes mellitus type 1 and disordered eating: A case report and literature review.

(2-177) Evaluation of Hyponatremia at Elevation: A Retrospective Review

(2-178) Expanding the Donor Pool: A Case Series Utilizing Hepatitis B NAT Positive Heart Transplant Allografts in Hepatitis B NAT Negative Recipients

(2-179) Pharmacodynamic Effects of Intra-Articular and Epidural Triamcinolone on Blood Glucose in Patients with Type-2 Diabetes

(2-180) Classic Psychedelic Treatment of Anxiety Disorders

(2-182) Business Proposal: Integration of clinical pharmacy services into the outpatient hematology-oncology setting

(2-183) Evaluation of Adherence to Long-Acting Injectable Naltrexone Post-Discharge in Patients with Substance Use Disorder in a Veterans Affairs (VA) Healthcare System

(2-184) Antibiotic Stewardship in the Emergency Department: Preliminary Impact of Rapid Diagnostics and Provider Education

(2-185) Impact of of allergy recommendation integrated antibiotic order-sets (AIAO) on the utilization of penicillin and cephalosporins in patients with anaphylactic allergy labels

(2-186) Antimicrobial Stewardship in Pediatric Emergency Departments and Discharge: A Systematic Review

(2-187) Kratom Products Exceed Safe Lead Levels in Children and Women of Child-Bearing Potential

(2-188) The Effects of Ketamine Treatment on Anxiety Disorders

(2-189) Risk of Charley Horse Pain with Insulin Titration in Patients with Type 2 Diabetes Mellitus

(2-190) The Impact of Fourth Year Pharmacy Student-Driven Medication Reconciliation in a Cardiac Surgery Step-Down Unit

(2-191) Evaluation of Intravenous Hypertonic Saline Administration Strategies among Patients with Acute Symptomatic Hyponatremia

(2-192) Evaluation of Calcium Repletion Order Set in Continuous Renal Replacement Therapy

(2-193) Evaluation of Nurse-Driven Heparin Protocol Compliance in Hospitalized Patients

(2-195) Evaluation of Pharmacist Impact on Time to Anticoagulation Reversal in the Emergency Department

(2-196) Factors Influencing Adherence to Follow-Up Dalbavancin Appointments in Intravenous Drug Users

(2-197) Unpacking Trends in ICU Cefepime and Piperacillin-Tazobactam Use

(2-198) A Systematic Review of Interventions to Reduce Pediatric Antibiotic Prescriptions: a focus on the research from resource-limited countries and multiple-site studies conducted in high-income countries

(2-199) Interventions to Reduce Pediatric Antibiotic Prescriptions in Pediatric Outpatient Clinics: A Systematic Review

(2-200) Impact of weight loss surgery on valproic acid levels

(2-201) Lithium-induced Psychogenic Polydipsia in a Patient with Schizoaffective Disorder

(2-202) Evaluating Drug Manufacturers’ Responses to Animal-Free Inquiries: A Nonsystematic Review of Accuracy, Response Time, and Impact on Patient Experience

(2-203) Nip by Nip: Assessing the Link Between Miniature Alcohol Sales and DUI Crashes

(2-204) Validation of a High Throughput Method for Bio-Sample Screening in Idiopathic Hypersomnia

(2-205) A Pharmacist’s Role in Navigating Pharmacokinetic Variables in Brain Death Determination

(2-206) The Therapeutic Potential of Salubrinal on the Pathophysiology of ME/CFS and Long- COVID

(2-207) Medication Usage Evaluation(MUE) Coagulation factor Xa and 4Factor PCC

(2-208) New FDA Approval: A Literature Review Supporting the Use of Pivya for Uncomplicated Urinary Tract Infections

(2-209) Balancing Patient Privacy and Healthcare Innovation: Addressing Trust and Ethical Concerns in Patient-Reported Outcome Data

(2-210) Comparison of New Alzheimer's Disease Treatments: Donanemab (Kisunla) and Lecanemab (Leqembi) Versus Established Therapies

(2-211) Impact on Health Outcomes and Medication Adherence of Patients Who Access Their Healthcare Portal in an Uninsured Population

(2-212) Pharmacists as a Resource for Reducing Health Disparities: A Literature Review

(2-213) Assessing the Influence of Socioeconomic Factors on Medication Adherence Among Older Adults Living with HIV in Low-income Communities

(2-214) An Assessment of Pharmacy Burnout Post COVID-19

(2-215) Impacting Effects of Post-Discontinuation of Injectable Semaglutide and Oral Semglutide on Weight and HbA1c in Type 2 Diabetes: POSITIVE-T2D

(2-216) Analyzing the African American pharmacist workforce in Central Florida and the effects of racial concordance on patient outcomes and health disparities

(2-217) Impact of Work on the Mental Health Status of Student Pharmacists and Faculty in Pharmacy

(2-219) The Role of Artificial Intelligence in Pharmacy: A Comparison of Clinical Interpretations

(2-220) Evaluation of the Timeliness of an Electrolyte Protocol at a Community Hospital System

(2-221) Hemoglobin-Based Oxygen Carrier-201 (HBOC-201) Use in Treating Life-Threatening Anemia Post-CABG in a Blood Refusal Patient Case

(2-222) Evaluating Liver Transplantation and Chemotherapy Ablation in Colorectal Liver Metastasis

(2-223) Examining Long-Acting Injectable Antipsychotic Prescribing and Transition of Care Practices in an Acute Behavioral Health Care Setting

(2-224) Impact of an Intensive Care Unit Pharmacist-to-Patient Ratio in a Community Teaching Hospital

(2-225) Review of the Investigational Use of Single, Dual, and Pan-Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

(2-226) HIV Co-infection with Mycobacterium Szulgiae: Clinical Insights and Management Challenges

(2-227) Sotatercept: Breathing New Life into Pulmonary Arterial Hypertension Treatment

(2-228) Enhanced Anti-inflammatory Effects of Liraglutide when Combined with Roflumilast in Cardiac Cells

(2-229) Investigating Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors for Safe and Effective Use in Heart Failure with Reduced Ejection Fraction: A Systematic Review of the Literature

(2-230) Navigating the Dual Challenges of Pain Management in Patients with Pain Syndromes and Cardiovascular Disorders: A Scoping Review

(2-231) Assessing Hospital Pharmacists' Knowledge and Perception of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Interventions, Patient Education, and Clinical Impact.

(2-232) Transformative Gene Therapies for Sickle Cell Disease: Exagamglogene Autotemcel and Lovotibeglogene Autotemcel

(2-233) Analysis of Analgesics Use for Management of Chronic Pain Conditions Among Adults Over Time

(2-234) Exploring the Emerging Therapeutic Applications of Glucagon-Like Peptide-1 Receptor Agonists Beyond Glycemic Control: A Comprehensive Review

(2-235) Rezdiffra (resmetirom), a novel therapeutic agent in the treatment of non-alcoholic steatohepatitis (NASH)

(2-236) Medication use Evaluation of post-intubation analgosedation at Memorial Hospital West Emergency Department

(2-237) Impact of integrated outpatient parenteral antimicrobial therapy (OPAT) pharmacy services on healthcare utilization

(2-238) Risk Factors for Hospital Readmission in Patients Discharged with Outpatient Parental Antimicrobial Therapy: An Observational Cohort Study

(2-239) Evaluating the Impact of Increased Utilization of Automated Pyxis Dispensing Systems on Hospital Pharmacy Workflow

(2-240) Empowering Pharmacy Services: The Future of On-Demand Technician Support

(2-241) Leveraging YouTube to Enhance Cervical Cancer Prevention: Insights from YouTube Content and Engagement Metrics

(2-242) Rx for Success: Teaching in the iGen Era

(2-243) Comparing Anticholinergic Load and As-Needed Medication Administrations in an Impatient State Psychiatric Hospital: A Retrospective Analysis

(2-244) Tripping or Triggered? Differential Diagnosis and Management of Hallucination Persistent Perception Disorder: A Clinical Case Report

(2-245) Use of Drugs Known To Cause Drug-Induced Liver Injury (DILI) Among Adults NHANES 2003-2020

(2-246) Mental Health Wellness Programs in the Top 20 U.S. Hospitals: A Best Practices Analysis

(2-247) BumpILY: A Pharmacist-Driven Prenatal Care Concept and Prototype

(2-248) Exploring the Role of Pharmacists in Infertility Management: A Scoping Review

(2-249) Clinical Presentation and Management of Hereditary Angioedema with Airway Compromise: A Case Report

(2-250) The Pressure Is On for Resistant Hypertension: The Use of Tryvio (aprocitentan) in Resistant Hypertension

(2-251) The Use of Quizartinib in Acute Myeloid Leukemia: A Review

(2-252) Trends in the History of Marijuana Use Among Adults in the United States, NHANES 2005-2018

(2-253) Impact of Pharmacist-Led Care on Clinical Health Outcomes for Underserved Populations in Federally Qualified Health Centers: A Systematic Review

(2-254) Management of Systemic Lupus Erythematosus Exacerbation in a Pregnant Patient: Role of the Critical Care Pharmacist

(2-255) Ceftobiprole: A Review of Evidence for the Novel Cephalosporin with Activity against MRSA

(2-256) Polypharmacy and Falls in the Elderly: A Systematic Review and Meta Analysis

(2-257) Linezolid Utilization Patterns Across a Level 1 Trauma Center

(2-258) Fruquintinib for the treatment of adult patients with previously treated metastatic colorectal cancer- a scoping review

(2-259) Psychopharmacology for the management of chemotherapy-induced cognitive impairment: a scoping review

(2-260) Shots of Protection: Pharmacy Students on the Frontlines of Flu, COVID-19, and Shingles Immunizations

(2-261) Complex Condition Interactions: A Case Study of Schizophrenia in a Patient with Traumatic Brain Injury

(2-262) Dead Woman Walking: A Closer Look at Cotard’s Syndrome as a Manifestation of Schizophrenia

(2-263) Examining the Potential of 3,4-Methylenedioxymethamphetamine (MDMA) for Treating Post - Traumatic Stress Disorder (PTSD) and Depression: A Scoping Review

(2-264) Real World Evidence: Demographic of South Florida Subethnic African American Women with Triple Negative Breast Cancer

(2-265) Under the Radar: Uncovering Arachnoid Cysts in Schizophrenia, Highlighting Differential Diagnosis

(2-266) Predictors of Human Papillomavirus (HPV) Vaccination Uptake among College Students in the United States

(2-267) TeleSlim

(2-268) Evaluating Cannabinoid Quality and Stability in Commercial Hemp Products: Implications for Abuse Prevention and Public Health

(2-269) Donanemab: Untangling the Web of Alzheimer's Care

(2-270) Evaluating the Treatment Outcomes and Recurrence of Clostridioides difficile Infections Following Fecal Microbiota Transplantation

(2-272) Evaluating Glucagon Utilization and Adherence to Protocol at JFK North: A Medication Use Evaluation

(2-273) Determining if Glucagon Administration Appropriateness Will Improve Before and After Nursing Education – A Quality Improvement Project

(2-274) Evaluation of Factor Eight Inhibitor Bypassing Activity (FEIBA) Administration for the Reversal of Direct Oral Anticoagulants (DOACs) in Patients at a Community Hospital

(2-275) Evaluation of Fidaxomicin Prescribing Patterns for the Treatment of Clostridioides Difficile in a Community-Based Health System

(2-276) Assessment of Inhaler Waste and Related Costs in Patients at a Community Hospital

(2-277) Off-Label Use of Teplizumab in a Patient with Early Stage 3 Type 1 Diabetes Mellitus

(2-278) Evaluation of a Nurse-Driven Clinical Institute Withdrawal Assessment for Alcohol Revised (CIWA-Ar) Protocol Within a Hospital System

(2-279) Assessing the Correlation Between Baseline Diabetes Knowledge and Point of Care Blood Glucose Results in Hispanic Individuals: A Pharmacists- and Student Pharmacists-Led Screening Study

(2-280) A Retrospective Chart Review of the Use of Guideline Directed Mediated Therapy in Patients with Heart Failure Referred for Pharmacy Consultation at a Community Hospital

(2-281) Exploring Pipeline Therapies: Are Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) and Glucose-dependent Insulinotropic Polypeptides (GIP) the Next Frontier for Metabolic Liver Disease?

(2-282) Clinical Presentation of Multiple Sclerosis (MS) Symptoms Leading to Multiple Sclerosis (MS) Diagnosis in Minority Populations in The United States

(2-283) Title: Exploring the Distribution of Community-Based Pharmacy Residency Programs in Medically Underserved Areas and Primary Care Health Professional Shortage Areas

(2-284) Evaluation of Antibiotic Selection for Open Fractures in the Emergency Department

(2-285) SGLT2 Inhibitors in Geriatric Care: A Risk-Benefit Decision-Making Approach

(2-286) Evaluating Safety and Efficacy of Intraosseous Vancomycin in Preventing Periprosthetic Joint Infections Following Revision Total Knee Arthroplasty: A 30 and 90-Day Outcome Analysis

(2-287) Pilot Study: Assessing Time to Antifungal Treatment using a Rapid Diagnostic Tool versus Conventional Blood Cultures for Detecting Candida in Positive Blood Cultures.

(2-288) Artificial Intelligence for Pharmacy Information and Education

(2-289) Midodrine safety in heart failure patients

(2-290) Translating Real-World Evidence into Practice: Improving Adherence, Persistence, and Tolerability to Oral Oncolytics in Patients With HR+/HER2- Breast Cancer

(2-291) Evaluation of antimicrobial management of neonatal patients with suspected or confirmed necrotizing enterocolitis and development of a standardized order set

(2-292) Ceftriaxone induced acute hepatic injury: a case report

(2-293) Evaluation of the Efficacy and Safety of 2-Infusion N-acetylcysteine in Pediatric Acetaminophen Toxicity

(2-294) Drug-Drug Interactions During Statin Associated Immune-Mediated Necrotizing Myopathy Treatment with Pharmacogenomic Implications

(2-295) Enhancing Compliance to CDC Opioid Guidelines in an Anesthesiology Pain Clinic

(2-296) Improvement of Allodynia following Discontinuation of Semaglutide in a Patient with Type 2 Diabetes Mellitus and History of COVID-19

(2-297) Evaluating the Efficacy of Enteral P2Y12 Inhibitors in Preventing Acute Stent Thrombosis Post-Percutaneous Coronary Intervention with Drug-Eluting Stents in ST-Elevation Myocardial Infarction with Cardiogenic Shock

(2-298) Evaluation of Written Patient Communication Journey on Registration Trends Within a Virtual Pharmacogenetics Consultation Service

(2-299) Evaluating Patient Awareness, Knowledge and Experience in a Pharmacogenetic Consult Clinic: Assessing Hispanic vs Non-Hispanic Population

(2-300) Assessing the Allocation of Community-Based Residency Programs in Socially Vulnerable Locations

(2-301) Addressing Glycemic Control Challenges After Removing Sulfonylureas from the Inpatient Formulary

(2-302) Cost Savings with Sacubitril-Valsartan: A Split Decision on Waste Reduction in a Hospital Setting

(2-303) Evaluation of Appropriate Oral Step-Down Therapy in Patients with Urinary Tract Infections Caused by Extended-Spectrum Beta-Lactamase Producing Escherichia Coli (E. coli)

(2-304) Evaluation of Clindamycin Utilization for Surgical Antimicrobial Prophylaxis in the Penicillin or Cephalosporin Allergic Patient

(2-305) Evaluation of Intravenous Levothyroxine Use at an Academic Medical Center

(2-306) Evaluation of Prescribing Patterns for the Treatment of Clostridioides difficile with Oral Vancomycin in a Community-Based Health System

(2-307) Intravenous immunoglobulin utilization patterns and cost analysis in a teaching hospital: one year later

(2-308) Cannabinoid Hyperemesis Syndrome: The Impact of Droperidol Use in the Emergency Department on Admission Rates

(2-309) Evaluation of Andexanet alfa for Direct Oral Anticoagulant (DOAC) Reversal

(2-310) HIV Pre-Exposure Prophylaxis Care Continuum in Outpatient Settings: A Systematic Review and Meta-Analysis

(2-311) Usability Evaluation of Pharmacogenomic Clinical Decision Support at a Large Academic Medical Center

(2-312) Analysis of Total Parental Nutrition (TPN) in post-transplant patients

(2-313) DNA Mutational Profiling in Colorectal Cancer: A Focus on the RNF43 Mutation

(2-314) Increasing adherence to scheduled patient encounter times in an outpatient oncology clinic

(2-315) Prolonged Discrepancy in Methotrexate Level Assays After Glucarpidase Administration

(2-316) Racial Disparity in Cardiovascular Adverse Events of Aromatase Inhibitor Use in Breast Cancer

(2-317) Pharmacogenomic Phenotyping Via Salivary pH Modifications

(2-318) Rebound Menopausal Vasomotor Symptoms with Concomitant Use of Caffeine and VEOZAH® (fezolinetant)

(2-319) Florida Gators Want You! To Implement a Pharmacy Skills Lab Teaching Assistant Program

(2-320) Is it a Win-win? Student Perceptions on the Benefits of a Skills Lab Teaching Assistant Program

(2-321) Impact of a Student Pharmacist Teaching Assistant Program on Career Interest and Abilities within Pharmacy Academia

(2-322) An Analysis of Physician-Reported Adverse Events in Florida’s Medical Marijuana Use Registry

(2-323) Assessing Time Savings and Provider Satisfaction in a Pharmacy-Led Transitions of Care Service

(2-324) Establishing the True Effectiveness of Pharmacist-Led Comprehensive Medication Reviews on Healthcare Outcomes

(2-325) Impact of Pharmacy-Led Medication History Pilot Program on Medication Discrepancies

(2-326) Retrospective study of testosterone use in gender-affirming therapy and adherence to testosterone prescribing guidelines

(2-327) Extended-Release Tacrolimus Dosing in Obese Kidney Transplant Recipients

(2-328) Implementation of Wellness Days for Pharmacy Students during Advanced Pharmacy Practice Experiences

(2-329) Evaluation of Safe Use of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors at an Academic Medical Center

(2-330) Hypophosphatemia Associated with Ferric Carboxymaltose: a Real-World Experience of a Hidden Complication

(2-331) Incidence of Venous Thromboembolism Post-Spontaneous Intracerebral Hemorrhage

(2-332) Evaluation of Nitroprusside Infusions in Cardiothoracic Surgery Patients in a Community Hospital

(2-333) Evaluating Changes in Prescription Patterns of Sodium Glucose Co-transporters inhibitors (SGLT2i) and 30-Day Readmissions in Heart Failure (HF) Patients Following Guideline Updates and Internal Interventions

(2-334) Central Catheters and Thromboembolism in Pediatric Patients with Cardiac Disease

(2-335) Quality Improvement: Evaluation of Medication Safety Practice Utilization in a Doctor of Pharmacy Curriculum

(2-336) Assessing the Relationship Between Job-Related Factors and Pharmacists’ Perception of Satisfaction with Work Conditions

(2-337) Incidence of Hypocalcemia in Trauma Patients After Receiving Massive Transfusion at a Level 2 Trauma Center

(2-338) Evaluation of Amiodarone Prescribing Trends

(2-339) Increasing Utilization of Statins in Type 2 Diabetes Patients

(2-340) Ambulatory Guideline-Directed Medical Therapy in Heart Failure with Preserved Ejection Fraction: Real-World Data from a Large Academic Center Cohort

(2-341) Evaluation of Alternative Drugs and Therapies Used by Patients in a Student-Run Free Clinic

(2-342) Reviewing Effects of Pre-Intensive Care Unit Antidepressants on Post-Intensive Care Syndrome (REPAIR-PICS)

(2-343) Creation of a Tool to Assess Psychological Safety in Pharmacy Education Environments

(2-344) Implementation of Remote Physiologic Monitoring in an Accountable Care Organization

(2-345) Evaluate Time to Therapeutic Levels in Adult Patients Receiving Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolisms in a Community Healthcare System

(2-346) Medication Use Evaluation: Use of Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors

(2-347) Characterizing Pulmonary Edema After Naloxone Administration Using Real World Data

(2-348) Evaluation of Rabbit Antithymocyte Globulin Weight-Based Dosing in Pediatric Kidney Transplant Patients

(2-349) Impact of Pharmacist-Driven Pre-Transplant Education on Pediatric Renal Transplant Patient Outcomes

(2-350) An Evaluation of the Quality of Datapoints Used to Predict Student Progression-Related Events Within in a PharmD Program

(2-351) Analysis of influenza vaccination status in influenza-positive patients during the 2023-2024 influenza season

(2-352) Racial Disparities in Young Adult Kidney Transplant Recipients: A Retrospective Cohort Study

(2-353) Evaluating Patient Perceptions of Skin Disease during Pharmacist Interventions in Atopic Dermatitis

(2-354) Impact of Pharmacy Intern Interventions on Managing Hyperlipidemia in Patients with an LDL greater than 190 mg/dL

(2-355) Evaluation of International Normalized Ratio Values in Patients Receiving Warfarin Therapy Using Vizient’s International Normalized Ratio-Based Metric Performance

(2-356) Octreotide to Prevent or Reduce Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices

(2-357) Utilization of Project BOOST (Building Optimal Outcomes through Strategic Training) in Evaluating Long-Term Impact of Immunization Training for Nigerian Pharmacists

(2-358) Complementary and Alternative Medicine: Bringing the Gap Between Evidence-Based Practice and Patient Preference

(2-359) Evaluation of the rate of euglycemic ketoacidosis as a significant adverse event associated with the usage of continuous renal replacement therapy

(2-360) Description of Services and Patient Experiences During a Multidisciplinary Medical/Surgical Mission Trip to Benin City, Nigeria

(2-361) To Crush, or Not to Crush, That Is the Question: Cinacalcet for a Patient with Hypercalcemia and Amyotrophic Lateral Sclerosis

(2-362) Compliance and Efficacy of High-Dose Droperidol Administration in Emergency Departments

(2-363) Evaluation of safety of direct oral anticoagulant use in older adults at a safety net academic medical center

(2-364) A multidisciplinary perspective on the feasibility of HIV pre-exposure prophylaxis being available over-the-counter

(2-365) Micronutrient Depletion in Extracorporeal Membrane Oxygenation: A Patient Case

(2-366) Assessing Dexamethasone Antiemetic Use in Patients Receiving Highly Emetogenic Chemotherapy with Immune Checkpoint Inhibitors

(2-367) Medication Use Evaluation of Glucarpidase Administration at an Academic Healthcare System

(2-368) Patient perspectives on Anal Cancer: A qualitative assessment of detection, diagnosis, and treatment considerations

(2-369) Rituximab and Paclitaxel Use in Anthracycline-Resistant Acquired Immunodeficiency Syndrome Related Kaposi Sarcoma Complicated by Castleman’s Disease - a Case Report

(2-370) Toeing the line with Angiotensin II: A Medication Use Evaluation

(2-371) Therapy Options in Refractory Anti-NMDA Receptor Autoimmune Encephalitis

(2-372) A comparison of states’ smoking and quit attempt rates by pharmacists’ authority to prescribe cessation medications

(2-373) Evaluating the Use of Apixaban for Atrial Fibrillation in End Stage Renal Disease Patients

(2-374) Highlighting the Impact of Tacrolimus Interactions on Transplant Patients

(2-375) Exploring Brugada Syndrome and Its Role in Sudden Cardiac Death: Pharmacological Management Strategies

(2-376) From Vacation to Critical Illness: A Case Report of Recurrent Sepsis in a Patient with Systemic Lupus Erythematosus: Diagnostic and Therapeutic Challenges

(2-377) Electronic health care record for objective structured clinical examination stations at Philadelphia College of Osteopathic Medicine School of Pharmacy Georgia Campus during 2022-2023 academic year

(2-378) Analyzing Alumni Trends for a New Pharmacy School: A Decade of Impact on Pharmacy Practice and Leadership

(2-379) Stellate Ganglion Block (SGB) Treatment of Post-Traumatic Stress Disorder: A Peer Review Analysis

(2-380) Cannabis Withdrawal Syndrome in Individuals With Chronic or Dependent Use of Cannabinoids: A Case Report

(2-381) Discovering the Therapeutic Potential of Mounjaro® (tirzepatide): A Case Report

(2-382) Enhancing Antibiotic Stewardship Through Interprofessional Collaboration

(2-383) Type 1 Diabetes Management Success with Tirzepatide, Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Use: A Case Report

(2-384) Monotherapy versus Combination Therapy Targeting Pseudomonas aeruginosa in Hospital-Acquired and Ventilator-Associated Pneumonia

(2-385) Recently Reported Adverse Effects of Miscellaneous Antibiotics

(2-386) Use of Virtual Influencers (VI) and Artificial Intelligence (AI) technology to optimize patient education

(2-387) Optimizing Statin Education: Impact of Counseling Formats on Patient Understanding and Retention Phase 2 – Development of Visual and Auditory Educational Material

(2-388) Semaglutide vs Liraglutide and The Difference in The Cardiovascular Benefits of These Medications

(2-389) Assessing Instructional Strategies: Metaphor-Based Videos vs. Traditional Handouts in Pharmacy Course

(2-390) Current Strategies and Future Dimensions in the Development of Kirsten Rat Sarcoma Virus Inhibitors for Targeted Anticancer Therapy

(2-391) Impact of Labetalol vs. Methyldopa on Infant Outcomes in Severe Pre-eclampsia: A Retrospective Review

(2-392) Investigating Student Professionalism during Advanced Pharmacy Practice Experience, Preceptors versus Students

(2-393) Assessing Inappropriate Medication Prescribing in Patients with Chronic Kidney Disease Discharged from the Emergency Department

(2-394) Optimizing Statin Education: Impact of Counseling Formats on Patient Understanding and Retention: Phase 3- Evaluation of Educational Materials

(2-395) Implementation of Cardiology Provider Report Cards to Improve Heart Failure Guideline-Directed Medical Therapy Prescribing

(2-396) Optimizing Statin Education: Impact of Counseling Formats on Patient Understanding and Retention Phase 1 – Development of Educational Materials and Assessment Tools

(2-397) A Retrospective Review of the Distribution of Use between Calcium Channel Blocker Compared to Beta Blocker therapy in Hypertensive Crisis

(2-398) Interprofessional Student Perspectives and Knowledge of Oncology

(2-399) Evaluation of Rates of Fentanyl Overdose with Co-Morbid Skin and Soft Tissue Infection

(2-400) Analyzing the Relationship between SSRIs/SNRIs and Hypertension

(2-401) Desk-Bound Recess: The Impact of Exercise on Pharmacy Students’ Blood Pressure

(2-402) Effects of Low-Intensity Physical Activity Breaks on Engagement: From a Pharmacy Student and Professor Perspective

(2-403) Impact of Physical Activity Breaks on Student Pharmacist Mood and Burnout

(2-404) Addressing Healthcare Gaps for Women: The Pharmacist's Role in Improving ECHO Outcomes Aligned with Healthy People 2030 Objectives

(2-405) Community Pharmacist Diabetes Care Services

(2-406) Characterization of Emergency Department Visits and Hospital Admissions for Pediatric Patients with Type 1 Diabetes Mellitus

(2-407) Mapping Georgia's Retail Pharmacies: An analysis of access to care among Georgia's rural and urban communities.

(2-408) Evaluation of Parenteral Anticoagulant Utilization for Venous Thromboembolism Prophylaxis in High-Risk Obstetric Patients

(2-409) Medication Process Evaluation of Bowel Regimen Initiation and Timing in Patients on Patient-Controlled Analgesia (PCA)

(2-410) Evaluation of Seizure Recurrence in Patients Administered an IV Loading Dose of Levetiracetam for Breakthrough Seizures in an Emergency Department

(2-411) Gabapentin reduces narcotic exposure in infants after stage II palliation

(2-412) Comparison of Adjusted Vancomycin Regimens Calculated by Intermittent Infusion (IIF) Versus Area Under the Curve (AUC) Methods.

(2-413) Comparison of Initial Vancomycin Regimens Calculated by Intermittent Infusion (IIF) Versus Area Under the Curve (AUC) Methods

(2-414) Evaluating Pharmacists' Confidence and Perceptions in Ambulatory Care Pharmacy Services: A Comparison Between Low and High Prescription Volumes

(2-415) From Barriers to Breakthroughs: The Role of Pharmacy in Reducing Emergency Department Visits through Medication Assistance Programs

(2-416) Analysis of the Utilization of Intravenous (IV) Acetaminophen in the Perioperative Setting After Cardiothoracic Surgery

(2-417) Analysis of Pharmacokinetics and Treatment Failure with Intravenous Push Cefepime in Critically Ill Patients with Sepsis

(2-418) Comparison of Patient Outcomes in Different Intensive Care Units at an Academic Medical Center: an OPTIM Analysis

(2-419) Effect of Consistent Clinical Pharmacy Personnel Coverage During First 48 Hours of ICU Stay on Patient Outcomes for Patients with Weekday Admission: an OPTIM Analysis

(2-420) Effect of Pharmacist Rounding Time on Patient Outcomes: A Subgroup Analysis of the OPTIM Study

(2-421) Impact of Pharmacists Rounding on an Intensive Care Unit Patient on Their First Day of Admission on Patient Outcomes: An OPTIM Subgroup Analysis

(2-422) Impact of Weekday vs Weekend ICU Admissions on Patient Outcomes: An Optimizing Pharmacist Team-Integration for ICU Patient Management (OPTIM) Subgroup Analysis

(2-423) Resuscitation Fluid Dosing Using Ideal Body Weight in Septic Shock: Impact on Vasopressor Requirements

(2-424) Comparison of Medication Turnaround Times for Intravenous Push versus Piggyback Administration of Levetiracetam Doses >1500 mg at an Urban Safety Net Hospital

(2-425) Evaluation of Carbapenem Prescribing Practices for Non-bloodstream Extended-Spectrum-Beta-Lactamase (ESBL) Infections at an Academic Medical Center

(2-426) Evaluation of Remdesivir Use at an Academic Medical Center

(2-427) Extended Spectrum Beta-Lactamase (ESBL) Escalation Alerts from Rapid Blood Culture Identification via Polymerase Chain Reaction Testing

(2-428) Leveraging Electronic Medical Record Education for Antimicrobial Stewardship in Enterococcus faecalis Bacteremia

(2-429) Medication Use Evaluation of Levofloxacin for Stenotrophomonas maltophilia Infections

(2-430) Real-world Evaluation of Adherence to Fluconazole Duration during Consolidation and Maintenance Phases in Patients with HIV-associated Cryptococcosis: A Claims-Based Study

(2-431) Evaluating the Usability of a Mobile Micro-Learning Application on Over-the-Counter Contraception and Opioid Safety Products for Use by Community Pharmacists

(2-432) Comparing Pharmacy Student Confidence in Accreditation Council for Pharmacy Education Standards Before and After Completing Advanced Pharmacy Practice Experiences

(2-433) Five Year Outcomes of a Multi-campus, Multi-semester Applied Critical Care Research Elective

(2-434) Assessing areas of improvement for five Georgia counties with the lowest annual household income and other key social determinants of health

(2-435) Health Outcomes and Social Determinants of Health in Rural Counties

(2-436) Evaluating the Effects of a Pilot Mobile Micro-Learning Application on Community Pharmacist Comfort and Confidence regarding Over-the-Counter Contraception and Opioid Use Disorder Products

(3-001) Utilization of Diabetic Medications Following the Hurricanes in Puerto Rico Compared to Hawaii 2016 to 2022

(3-002) Pharmacotherapy Interventions in Ventilator Care Bundles for Preventing Ventilator-Associated Pneumonia in Adults: A Literature Review

(3-003) Development of a Comprehensive Interaction Database Between Hawaiian Medicinal Herbs and Anticancer Drugs

(3-004) Asian Participation in Clinical Trials Leading to First FDA Approval for Top 10 Forecasted Drug Products in 2024

(3-005) Evaluation of Patient Eligibility for Continuous Glucose Monitor Utilization at the East Hawaii Health Primary Care Clinic

(3-006) Examining Adverse Effects Reported to the FDA on Glucagon-Like Peptide-1 Receptor Agonists and Glucagon-Like Peptide-1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists

(3-007) Retrospective Evaluation of Piperacillin-Tazobactam Utilization in General Surgery Patients within a Medical Center

(3-008) Comparing Systolic and Diastolic Blood Pressure Values from Eight Different Cities on Hawai’i Island

(3-009) Assessing Pharmacist Impact on Lipid-Lowering Medication Prescribing in Patients with Diabetes in a Rural Setting

(3-010) An Analysis of US FDA Approved New Drug Therapies in 2024

(3-011) Evaluation of Renal-Protective Medication Use in Patients with Type 2 Diabetes and Chronic Kidney Disease in a Primary Care Clinic

(3-012) Evaluation of Droperidol Use for Acute Agitation in the Emergency Department

(3-013) Impact of pharmacist-led diabetes prevention programs on weight loss in a rural Hawaii community

(3-014) Examining the US FDA Approved Glucagon-Like-Peptide-1 Receptor Agonists from 2005-2024

(3-015) Evaluation of 2021 Standardized Antimicrobial Administration Ratios for Broad-Spectrum and Gram-Positive Antimicrobials with Nationwide Rates of Healthcare Associated MRSA and Multidrug Resistant Pseudomonas Aeruginosa

(3-016) Comparison of Substance Abuse Rates of Drug Groups (Fentanyl, Cocaine, Cannabis, Heroin, Opiates, Amphetamines) within the United States Army Prior to, During, and Post-COVID-19 Pandemic

(3-017) Comparison of Medicare Semaglutide and GLP-1 Receptor Agonists Prescribing Claims and Kidney Disease Deaths by State in 2022

(3-018) Addressing Counterfeit Risks and Shortages in the United States Drug Supply Chain: The Case of Semaglutide

(3-019) Comparison of Illicit Drugs of Abuse Usage Rates Among the Army Reserve and the Active Army in 2024

(3-020) Warfarin management in a rural physician-run clinic: Efficacy of In-Clinic Testing Compared to Home Monitoring

(3-021) Implementation and evaluation of cascade reporting on antimicrobial stewardship and promoting the use of narrow-spectrum antibiotics

(3-022) Prevalence and Dosing of Direct Oral Anticoagulants in the Management of Left Ventricular Thrombus

(3-023) Community Pharmacists in Medication-Assisted Therapy for Opioid Use Disorder: Facilitating Positive Outcomes Through Prescribing, Patient Management, and Primary Care Referrals

(3-024) Study Plan for a Case-Series of Medication Claims from Community Pharmacies in Idaho

(3-025) In Vitro Analysis of Embelin in Combination with Tyrosine Kinase Inhibitors for Treating Breast Cancer

(3-026) Let's Take a Trip! The Use of Psychedelic Compounds to Treat Mental Illness

(3-027) Overcoming Compliance Barriers: Enhancing Medication Adherence in Transplant Patients through an Integrated Health-System Mail Order Pharmacy Approach.

(3-028) Prevalence of Chinese Americans Eligible for Diabetes Screening: The Impact of Race-Specific BMI Thresholds

(3-029) Tolerance of Direct Cefazolin Use in Penicillin Allergic Patients with Moderate-to High-Risk for a Drug Allergy Reaction

(3-030) Assessing the Validity and Scientific Accuracy of Social Media “TikTok” Videos Surrounding Oral Contraception

(3-031) Mantle Cell Lymphoma - Dose Reduced Bendamustine in Severe Hepatic Impairment

(3-033) Evaluating the Influences on Pharmacy Students’ Professional Identity: A Longitudinal Study

(3-034) C-Reactive Protein as a Biomarker and Potential Therapeutic Option in High-Grade Serous Ovarian Cancer

(3-036) Prostate Cancer Prevalence in the United States

(3-037) Opioid antagonist Utilization Patterns in United States Emergency Department Visit: A Retrospective Study

(3-038) The Use of Artificial Intelligence in a Thematic Analysis of Performance Evaluation in Advanced Pharmacy Practice Experiences

(3-039) Illinois Council of Health-System Student Chapter Activities at Rosalind Franklin University

(3-040) What All Community Pharmacists Should Know About Veterinary Pharmacy and the Impact of an Educational Intervention

(3-041) Osteomyelitis in Pediatrics: Comparing Methicillin Resistant Staphylococcus aureus and Methicillin Sensitive Staphylococcus aureus Rates and Empiric Treatment at a Tertiary Care Center

(3-042) Prepping for the Future: An Evaluation of Healthcare Provider Prescribing Practices of HIV PrEP and PEP Medication Regimens

(3-043) Evaluating Antibiotic Use for Code Sepsis in the Emergency Department - A Retrospective Chart Review

(3-044) Evaluating the Implementation of 2022 ACC/AHA Guidelines for HFrEF: Prescribing of First-Line Therapies in Clinical Practice

(3-045) Assessing the Role of Vital Signs in Symptom-triggered Alcohol Withdrawal Scoring: A Retrospective Evaluation of the Alcohol Withdrawal Assessment Scale

(3-046) Evaluation of Intravenous Iron Replacement Therapy in a Community Teaching Hospital

(3-047) Impact of a Rapid Multiplex Polymerase Chain Reaction Blood Culture Identification Panel and a Pharmacist-driven Protocol on Antibiotic Management

(3-048) Role of Dapagliflozin in Attenuating Renal Tubule Damage: Immunohistochemical Analysis of a Diabetic Rat Model

(3-049) Analysis of Amoxicillin-Clavulanate Prescribing in Pediatric Primary Care

(3-050) Assessing the Efficacy and Safety of Undiluted Levetiracetam for Rapid Intravenous Push in Pediatric Emergency and Inpatient Settings

(3-051) Indomethacin Risk and Reward after 7 Days of Age in Neonates

(3-052) On-time Administration of Scheduled Albuterol in the Emergency Department

(3-053) The Impact of Interprofessional Collaboration on Pharmacy Students’ Learning in Maternal Health Emergencies

(3-054) Exploring the Relationship Between Sense of Belonging and Burnout Experience Among Pharmacy Students: A Quantitative-Comparative Study

(3-055) Impact of Pharmacist-Led Insulin Pump Service in Primary Care

(3-056) Aspirin Use for Secondary Cardiovascular Disease Prevention in Jamaica: Adherence and Barriers

(3-057) Evaluating Twice Daily versus Thrice Daily Low Dose Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Elderly Hospitalized Patients

(3-058) Deprescribing Education in US Schools of Pharmacy

(3-059) Appropriate Discharge Antibiotic Selection, Dosing, and Duration for Urinary Tract Infections in the Emergency Department and Implications for Pharmacist Intervention

(3-060) Evaluating the Accessibility of Automated External Defibrillators in a Community Setting

(3-061) 7 Versus 14 Days of Antibiotic Therapy for Uncomplicated E. coli and K. pneumoniae Bacteremia: A Retrospective Study

(3-062) Impact of an Infectious Disease Consultation on Duration of Antibiotic Therapy in Uncomplicated Gram-Negative Bacteremia

(3-063) Reassessment of Documented Penicillin Allergies: Implications on Antibiotic Selection and Reaction Outcomes in Hospitalized Adults

(3-064) Optimizing Buprenorphine Initiation for Opioid Use Disorder in the Inpatient Setting: A Retrospective Chart Review

(3-065) Impact of COVID-19 on School Aged Children and Adolescent Mental Health

(3-066) Assessing the Attitudes, Perceptions, and Practices of Pharmacists Towards Deprescribing

(3-067) Assessing Organ Donation Registration Knowledge and Association with Blood Donor Status

(3-068) Evaluation of Pharmacists' and Student Pharmacists' Perspectives on the Development of a Women's Health Pharmacotherapy Course

(3-069) Treatment of urinary tract infections in infants less than 2 months of age

(3-070) Awareness and Perceptions of Fentanyl Criminalization Policies: A Survey Report

(3-071) Effectiveness of the University of Illinois Chicago Herbert M. and Carol H. Retzky College of Pharmacy’s Revised Teaching Methods on Visiting International Students

(3-072) Average Length of Stay in the Emergency Department When Prescribed an Intravenous or Oral Cephalosporin for Uncomplicated Urinary Tract Infections

(3-073) Improving Access to Long-Acting Antipsychotic Injectables within a Federally Qualified Health Center

(3-075) Retrospective Analysis of the Medications Taught in Pathophysiology, Drug Action, and Therapeutics Courses at the University of Illinois, Retzky College of Pharmacy

(3-076) Taking the Plunge Together: A Student-led Faculty Learning Seminar Series on Artificial Intelligence

(3-077) Improving Pediatric Venous Thromboembolism Risk Assessment: A Quality Improvement Initiative

(3-078) Cardiogenic Shock in the setting of Epstein-Barr Virus-Associated Myocarditis

(3-079) Prosthetic Peril: A Case Study of Penile Prosthesis Infection

(3-080) Characterizing Electronic Medical Record (EMR) Secure Chat Data in a Health-System Specialty Pharmacy

(3-081) The Effects of Implementing a Call Center on Workflow and Break in Tasks in an Ambulatory Care Pharmacy

(3-082) Acute Pancreatitis and Euglycemic Non-diabetic Ketoacidosis Caused by an Intentional Semaglutide Overdose

(3-083) Development of a Database for Measuring and Recording the Complexity of Studies Employing Investigational Drug Services

(3-084) Management of Complex Medication Regimens and the Universal Medication Schedule: An Interprofessional Skills Lab

(3-085) Adoption of Adalimumab Biosimilars Within Outpatient Pharmacies in a Health System

(3-086) Analysis of Pharmacist-Led Lab Reviews for Patients Treated with Capecitabine in a Health System Specialty Pharmacy

(3-087) Evaluating the Effects of Home Medication Delivery on Medication Adherence in Pediatric Patients with Sickle Cell Disease

(3-088) Hepatitis A and B Vaccine Administration‬ Practices in the Illinois Department of Corrections‬ Facilities‬

(3-089) Evaluating Biologic Discontinuation Reasons in Rheumatoid Arthritis and Psoriatic Arthritis: A Retrospective Analysis

(3-090) A Retrospective Study Comparing Pharmacist and Nurse Collaboration to Standard of Care Obesity and Overweight Treatment and Outcomes in Primary Care

(3-091) Effect of Vitalograph Aerosol Inhalation Monitor Implementation on a Multidisciplinary Chronic Obstructive Pulmonary Disease (COPD) Clinic

(3-092) Dual Antiplatelet Therapy Compared to Therapeutic Anticoagulation Status-Post Left Atrial Appendage Occlusion

(3-093) Pharmacogenomic guided optimization of P2Y12 inhibitor therapy

(3-094) Utilization of Effective Diuresis in Patients Admitted for Acute Decompensated Heart Failure

(3-095) Readmission Rates Following Co-Administration of Tetracycline or Fluoroquinolone Antibiotics with Divalent and Trivalent Cations in Hospitalized Patients for Treatment of Bacterial Infection

(3-096) Appropriate Adjustments of Inpatient Insulin Regimens after Recurrent Hyperglycemic Events

(3-097) Retrospective Analysis of Parenteral Nutrition Provided in a Level III Neonatal Intensive Care Unit (NICU)

(3-098) Evaluation of antiretroviral medications across a multi-hospital community health system

(3-099) Oral Antimicrobial Optimization for the Treatment of Uncomplicated Gram-Negative Bloodstream Infections

(3-100) Utilization of Pneumococcal Urinary Antigen Testing to Streamline Antibiotics in Patients with Suspected Community Acquired Pneumonia

(3-101) Buprenorphine for Pain Management Clinical Education Research Project

(3-102) Evaluating Practice Readiness After a Curriculum Change Integrating Important 200 Medications into Pharmacotherapeutics Courses.

(3-103) Impact of a Pharmacist-Led Heart Failure (HF) Guideline Directed Medical Therapy Titration Clinic on HF Related Emergency Department Visits and Hospital Readmissions

(3-104) Exploring Characteristics of Patients Potentially Eligible for Transition from Warfarin to Direct Oral Anticoagulants: A Descriptive Study in an Anticoagulation Clinic

(3-105) Impact of Antimicrobial Cascade Reporting on Broad-Spectrum Antibiotic Use in the Treatment of Gram-Negative Infections

(3-106) Utility of Direct Oral Anticoagulants (DOACs) in the Treatment of Pediatric Venous Thromboembolism (VTE)

(3-107) Blood Factor Utilization Evaluation in Cardiovascular Surgery

(3-108) Impact of Vial Splitting on Sugammadex Utilization and Spending

(3-109) The impact of PGx testing for HLA-B*57:01 when using Abacavir

(3-110) Outcomes from IPE Crossover Master of Athletic Training Core Content and PharmD Elective Courses

(3-111) Empiric Vancomycin Dosing in Pediatric Patients at a Community Hospital in Northern Indiana

(3-112) Pharmacy Education Technology with Artificial Intelligence: Revolutionizing Student Feedback Analysis for Optimizing Pharmacy Education and Instruction.

(3-113) Evaluation of a Charitable Medication Access Program and Healthcare Resource Utilization in an Urban Academic Medical Center

(3-114) Evaluating the Use of Double Anerobic Coverage Within a Critical Access Hospital

(3-115) Retrospective Analysis of Titration of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Beta-Blockers in Patients Post Acute Myocardial Infarction

(3-116) Medication Use Evaluation of Phytonadione at a Community Hospital in Northern Indiana

(3-117) Service evaluation into the use of inclisiran across North East London in a pharmacist led clinic at St Bartholomew’s Hospital (SBH)

(3-118) Empowering Patients Living with Hypertension: Patients’ Perceptions and Acceptability of Home Blood Pressure Monitoring in a Federally Qualified Health Center

(3-119) Impact of an Accountable Care Organization Pharmacy Team’s Outreach for Statin Use in Patients with Diabetes or Cardiovascular Disease: A Retrospective Analysis

(3-120) Rivaroxaban Adherence for Venous Thromboembolism Prophylaxis in Hospitalized Patients with Sickle-Cell Disease

(3-121) Evaluation of Appropriate Monitoring and Management of Digoxin

(3-122) Single Center Evaluation of Remodulin/Flolan for Pulmonary Arterial Hypertension Treatment

(3-123) Examining Deviations from Intravenous Vancomycin Protocol in Adult Patients

(3-124) Minimization of Caregiver Impact with the Use of Ribavirin in Non-Solid Dosage Forms

(3-125) Systematic Review of Machine Learning Technology to Identify Patients at Risk for Adverse Medication Events

(3-126) Impact of Supervised Advanced Prescribing Practices on Key Performance Indicators (KPIs) for Lung Systemic Anticancer Therapy (SACT)

(3-127) Assessing Appropriateness of Liposomal Bupivacaine for Treatment of Post-Surgical Pain

(3-128) Characterizing Interventions to Support Caregivers Managing Medications and Feeding for Medically Complex Children-A Scoping Review

(3-129) Assessment of As Needed Pain Medication Utilization in an Academic Medical Center: A Descriptive Review

(3-130) Assessment and Exploration of Whole Brain Preferences and Communication Styles of Student Pharmacists Participating in International Advanced Pharmacy Practice Experience in Medellin, Colombia

(3-131) Health Education Needs Assessment: Education and Implementation at an Innovation Center for Street Youth in Eldoret, Kenya

(3-132) The Application of Psychostimulants for Methamphetamine Use Disorder in a Public Health Setting: A Case Series Review

(3-133) Evaluating the Appropriateness and Utilization of a Pharmacist Referral Service for the Prescribing of Nirmatrelvir/Ritonavir in Outpatient Settings

(3-134) PREVENT and ASCVD Risk Calculators: Estimating 10-Year and 30-Year Patient Risk and Impact on Treatment Recommendations

(3-135) Evaluating the Impact of a Virtual Post-Acute Myocardial Infarction (AMI) Clinic in Lipid Management

(3-136) Safety and Efficacy of Full Intensive Phase Apixaban and Rivaroxaban following Extended Duration Parenteral Anticoagulation for the treatment of Acute Venous Thromboembolism

(3-137) Vitamin K Medication Use Evaluation at a Large Community Health System.

(3-138) Pegfilgrastim Administration via Prefilled Syringe vs. On-body Injector in Pediatric Patients

(3-139) Comprehensive Analysis of Pain Management Strategies in the Adult Critical Care Unit (ACCU) Following Cardiac Surgery at a Cardiac Specialty Hospital in London, UK

(3-140) Riley Maternity Tower Perinatal Headache Management: Medication Usage Review

(3-141) Enhancing Pharmacists’ Drug Consultation Services: Outcomes of an EPA-Based Outpatient Counseling Training Program

(3-142) Evaluation of Belimumab (Benlysta®) use in Daegu Catholic University Medical Center (DCUMC)

(3-143) Analysis of Dispensing Errors after Implementation of Intelligent Mobile Dispensing Management System: 7 Years Later

(3-144) Exploration of the Mechanism Underlying Muscle Sensitivity to Oxidative Atrophy in Chronic Kidney Disease

(3-145) Performance improvement of a natural language processing system to extract information from patients' complaints in pharmacist records -Effects of additional training using community pharmacy data-

(3-146) Optimizing Anticoagulation Therapy in Saudi Arabia: The Evaluation of Pharmacist-Led Interventions on Physician Acceptance and Patient Care

(3-147) Real-World Evaluation of the Safety and Effectiveness of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Two-Center Retrospective Cohort Study

(3-148) Reducing Inappropriate Proton Pump Inhibitors (PPIs) Prescriptions by Implementing Deprescribing Strategies Among Geriatric Patients in Home Healthcare Settings (HHC)

(3-150) Establishment of Guidelines for ‘Antibiotic Skin Test(AST)’ to Ensure Safe Use of Antibiotics

(3-152) Expansion of ScriptCenter Prescription Locker Service for Patient Pick-Up at the Johns Hopkins Bayview Community Pharmacies

(3-153) Utilizing pharmacogenomic tests to optimize pain management therapy in patients with rheumatological conditions at the Ambulatory Clinics of the University of Puerto Rico.

(3-154) The Diabetes Distress Scale and the Effects on Management of Glycemic Control

(3-155) Assessing Health Literacy in Patients with Diabetes

(3-156) Doxorubicin Treatment Enhances B-Raf Degradation in Human Cancer Cells

(3-157) Evaluation of Vancomycin Dosing in Larger Adolescents and Young Adults

(3-158) Micro-credentials in Pharmacy Education

(3-159) Evaluation of Pharmacy Specialist Involvement in the Medication Appeal Process at an Academic Medical Center

(3-160) Use of Guideline-Directed Heart Failure Therapy in Patients Using University of Iowa Health Care Pharmacy Services

(3-161) Evaluating Patient Eligibility of Switching from Warfarin to a Direct Oral Anticoagulant in an Anticoagulation Case Management Service

(3-162) Evaluation of Pharmacist versus Physician Led Inpatient Warfarin Management

(3-163) Evaluation of Cephalosporin Allergies in Obstetric Patients

(3-164) Impact of Corticosteroid Use on Patient Outcomes in Individuals with Influenza and Lung Disease

(3-165) Impact of Biologic Therapy on Inhaled Corticosteroid Dosing in Severe Asthma: A Retrospective Chart Review

(3-166) Assessing the Administration of Tranexamic Acid for Trauma Patients Presenting to a Community Hospital Emergency Department

(3-167) Characterization of Bacterial Cultures in Sepsis Patients Presenting to an Academic Medical Center

(3-168) Assessment of Oral Immunoglobulin Therapy in Managing Norovirus-Associated Diarrhea in Pediatric Kidney Transplant Recipients

(3-169) Evaluation of Specialty Pharmacy Efficiency in Patient Outreach After Implementation of Texting Platform

(3-170) Subcutaneous semaglutide overdose: a case report and literature review

(3-171) Assessing Steroid-Sparing Premedication De-escalation in Paclitaxel Regimens

(3-172) Comparison of Dextrose 10% and Dextrose 50% Boluses in the Prevention of Iatrogenic Hypoglycemia Following Intravenous Insulin for Hyperkalemia

(3-173) Palonosetron: A Medication- Use Evaluation at an Academic Medical Center

(3-174) Rituximab Medication-Use Evaluation at an Academic Medical Center

(3-175) Terlipressin Usage: A Medication-Use Evaluation at an Academic Medical Center

(3-176) Upadacitinib Prescribing Practices: A Medication-Use Evaluation at The University of Kansas Health System

(3-177) Evaluation of Antibiogram versus Patient-Specific Risk Factor Pathway to Optimize Empiric Antibiotic Therapy for Gram-Negative Bacterial Pneumonia in the Intensive Care Unit

(3-178) Evaluation of Single-Dose Gentamicin for Uncomplicated Urinary Tract Infections in the Emergency Department

(3-179) Assessing Levetiracetam Prophylaxis for Neurocritical Care: Insights from a Community Hospital

(3-180) Evaluation of Dornase Alfa Use Within a Pediatric Institution

(3-181) The Multivitamin Mystery: A Medication-Use Evaluation at a Major Medical Center

(3-182) Evaluating Blood Culture Identification Results

(3-183) Examination of opioid use in robot-assisted versus manual total knee arthroplasty

(3-184) Pharmacogenomics Implementation Plan for Sertraline and CYP2C19 in Retail Pharmacy

(3-185) Evaluation of Sedation in Critically Ill Pregnant Patients

(3-186) Analysis of Intravenous to Oral Antibiotic Conversion of Doxycycline in a Community Hospital

(3-187) Aprepitant Medication Use Evaluation at an Academic Medical Center

(3-188) Medication Use Evaluation of Intravenous Aprepitant for the Prevention of Post-operative Nausea and Vomiting (PONV) in Patients Undergoing Bariatric Surgery

(3-189) Assessing Third-Year Pharmacy Students' Performance in Journal Club Milestones: A 2023-2024 Comparison

(3-190) Evaluating the impact of significant relationship status on career plans among PharmD students and residents.

(3-191) Evaluation of an Insulin Infusion Protocol in Laboring Patients

(3-192) Development of Pharmacy Technician Advancement Program for an Academic Medical Center

(3-193) Evaluation of Ceftriaxone Optimization

(3-194) Blood pressure control in patients with type 2 diabetes: a retrospective chart review of patients at a family medicine clinic in rural Kentucky

(3-195) Evaluation of Injectable Promethazine in the Ambulatory Setting at an Academic Health System

(3-196) Utilization of Guideline-Directed Medical Therapy (GDMT) in HeartMate 3™ Patients: a single center cohort study

(3-197) Daptomycin Pneumonitis Secondary to the Treatment of Osteomyelitis – A Case Report

(3-198) Stability of Naloxone Solutions in Normal Saline and 5% Dextrose in Water

(3-199) Factitious Hypoglycemia In Pregnancy: A Case Report

(3-200) Frequency and Characteristics of Healthcare Encounters in the Week Preceding Incident Sepsis Hospitalization: A Nationwide Observational Analysis

(3-201) Impact of Standard Versus Weight-based Maintenance Dosing of Fosphenytoin on Achieving Therapeutic Levels

(3-202) Sodium Balance in Hyponatremic Patients Receiving Custom Dilution Continuous Renal Replacement Therapy Fluids

(3-203) Evaluation of Opioid Dose Post-discharge in Orthopedic Trauma or Major Trauma Patients

(3-204) Patients Assessed for Hepatitis C Virus in the Emergency Department Have Discordant Fibrosis-4 and Transient Elastography Measurements

(3-205) Understanding the Impact of Pharmacist Prescriptive Authority on State Level PrEP Access

(3-206) Liposomal Bupivacaine Usage for Shoulder Arthroplasty and Rotator Cuff Repair at a Regional Teaching Hospital

(3-207) Enhancing Readiness for Acute Care Inpatient Advanced Pharmacy Practice Experiences (APPEs) Through Use of a Mini-Video Library: A Quality Improvement Project

(3-208) Stability Study to Clarify the Stability of Meropenem at Room Temperature

(3-209) Assessing Ulcerative Colitis Risk Modifiers in Patients Living in Appalachia

(3-210) Effects of Typical Antipsychotics Administration in Methamphetamine Exposed Patients in the Emergency Department: A Retrospective Cohort Study

(3-211) Impact of Quadruple mTOR-based Immunosuppression on Infection Outcomes in Lung Transplant Recipients

(3-212) Inpatient Use of Oral Extended-Release Opioids

(3-213) Evaluating the Appropriate Use of Pharmacy Calculations by Artificial Intelligence Models

(3-214) Off-label Use of Cabotegravir/Rilpivirine in a Patient Requiring Injectable Antiretrovirals

(3-215) Shifting Perspectives: Assessing Knowledge and Beliefs in Harm Reduction Strategies Among Future Healthcare Professionals – H.E.R.O. Harm Reduction and Opioid Education

(3-216) Pharmacy Adherence to Best Practices When Dispensing Liquid Medications for Children

(3-217) The Evaluation of Four-Factor Prothrombin Complex Concentrates Utilization Following a Formulary Preference Change at the Largest Academic Medical Center in Louisiana

(3-218) The Impact of Emergency Medicine Clinical Pharmacist Led Education on Nursing at a Level 2 Trauma Center

(3-219) Elevating Diabetes Education: Exploring Perceptions and Barriers of Patients to Diabetes Education in an Underserved Community

(3-220) Vasopressor Medication Use Evaluation: Vasopressor Use Through Peripheral Line Prior To Policy Initiation

(3-221) Evaluation of Intravenous Levothyroxine Use After Implementation of Restriction Criteria

(3-222) Evaluation of Fusarium Solani Osteomyelitis

(3-223) Evaluation of Plasmodium falciparum Malaria in the Presence of a Possible Coinfection

(3-224) Evaluation of an Our Practice Alert to Improve Apixaban Dosing Consistent with Prescribing Information in Patients with Non-valvular Atrial Fibrillation at an Academic Medical Center

(3-225) Managing CNS parasitic infections: A case of neurocysticercosis

(3-226) A College of Pharmacy Tele-Based Approach to Addressing Health Equity

(3-227) Correlation Analysis Between Fall and Fracture Occurrence in the Elderly Diabetic Population and Comorbid Conditions: a Quantitative Study

(3-228) Evaluating the Effectiveness and Safety of Direct Oral Anticoagulants (DOACs) Compared to Warfarin in Obese and Morbidly Obese Patients Taking Nonsteroidal Anti-inflammatory drugs (NSAIDs)

(3-229) Evaluation of Direct Acting Oral Anticoagulant Dosing and Duration in the Treatment of Venous Thromboembolism

(3-230) Clinical Trial Participation in the Gulf South: Assessing Awareness, Willingness and Barriers Among Minority Communities

(3-231) Socioeconomic Characteristics, Healthcare Trust, and Willingness to Participate in Clinical Trials Among Minority Populations in New Orleans

(3-232) Idiopathic and metabolic triggers leading to recurrent acute pancreatitis in a 30-year- old woman

(3-233) Redefining Patient Care: The Importance of Pharmacist-Led Initiatives in Enhancing Patient Advocacy

(3-234) A retrospective evaluation on the use of ENTRESTO® (sacubitril/valsartan) for heart failure at an academic hospital

(3-235) Bridging the Gap: Addressing Racial Disparities in Treatment Outcomes for Second-Degree Heart Block

(3-236) Risk of Recurrent Arrhythmias in Patients Receiving Amiodarone for New Onset Atrial Fibrillation in Critical Illness

(3-237) A Medication Use Evaluation of Calcitonin Restriction Guideline for Use in an Academic Hospital

(3-238) Evaluation of Antibiotic Prophylaxis in Patients admitted to University Medical Center New Orleans with Traumatic Facial Fractures

(3-239) In vitro Evaluation of Synthetic Polyphenol against SARS-CoV-2

(3-240) Evaluating the Impact of Remote Oncology Clinical Services

(3-241) Prior Authorizations: A Barrier to Lower Limb Revascularization in Peripheral Artery Disease

(3-242) Enteral Phosphate Repletion in Patients Receiving Continuous Renal Replacement Therapy

(3-243) Cost-Savings with Common Stock Insulin Vials

(3-244) Multi-year analysis of prescribing card implementation effectiveness at an express care center for first-line antibiotic therapy prescribing for uncomplicated cystitis

(3-245) Outcomes of Postgraduate Training Elective Course for Third-Year Student Pharmacists

(3-246) Frequency of Adverse Drug Events (ADEs) Due to Unexpected Reactions from GIP/GLP-1 Agonist and GLP-1 Agonists Used for Weight Loss

(3-247) Development of a ssDNA-based Sensing Platform for Environmental Toxicology

(3-248) Appropriate Indication of Long-Term Aspirin for Patients on Concurrent Warfarin Therapy at a Baltimore City Community Hospital Anticoagulation Clinic

(3-249) Enhancing Pneumococcal Vaccination Rates: Analysis of a Targeted Outreach Strategy in Patients with Type 2 Diabetes

(3-250) Biochemical changes underlying the neuroendocrine differentiation of prostate cancer cells.

(3-251) Evaluation of Service Implementation for High Resolution Anoscopy (HRA) in a Rural Clinic to Prevent Anal Cancer

(3-252) Impact of a Pharmacist-Led Medications of Abuse Review Program in Correctional Facilities

(3-253) Declining Pharmacy School Enrollment: Challenges and Opportunities of Provider Status

(3-254) Cost Effectiveness of Conversion From Tenofovir Alafenamide (TAF)-Based Regimen To A Two Drug Regimen Program In Correctional Facilities

(3-255) Niosomal Encapsulation of Curcumin for Overcoming Multidrug Resistance in Ovarian Cancer

(3-256) Synthesis of Trifluoromethylated Cyclic Enaminone Intermediate: Early Drug Discovery of Antiseizure Agents for Treatment of Refractory Epilepsy

(3-257) Evaluating the Economic Impact of Reducing HbA1c Levels in Patients with Diabetes

(3-258) Role of the Child Opportunity Index in Understanding Disparities in Healthcare Among Pediatric Populations

(3-259) Medication use evaluation of surgery prophylaxis antibiotic administration, selection, and timing at a small community hospital

(3-260) A retrospective medication use evaluation of appropriate piperacillin-tazobactam scheduling and administration following a loading dose

(3-261) Implementation of ScriptCenter Automation in a Federal Hospital Setting

(3-262) Optimizing Pharmacist Team Integration For Pediatric Intensive Care Unit Patient Management

(3-263) Optimizing Pharmacist Team-Integration for ICU Patient Management (OPTIM): Patient Outcomes Focusing on the Neonatal ICU Population.

(3-264) Terbutaline Continuous Infusion for Pediatric Status Asthmaticus: A Retrospective Chart Review

(3-265) Alteplase vs Tenecteplase in Acute Ischemic Stroke

(3-266) Oncology Patient Perspectives on Medical Cannabis Use in Maryland

(3-267) Quantifying nephrotoxin burden among hospitalized patients diagnosed with hospital-acquired acute kidney injury (HA-AKI) at an urban academic medical center.

(3-268) Clinical Evaluation of G-CSF Use in R-MPV for CNS Lymphoma

(3-269) Better Sleep: Enhancing Sleep Quality in Older Adults through Deprescribing

(3-270) Fluoxetine Mitigates Behavioral Alterations Induced by Chronic Mild Stress in Drosophila Melanogaster.

(3-271) Impact of the Federal Controlled Substances Act on Opioid Prescription Management in New England States: A Comparative Analysis

(3-272) Shifting Diagnoses: A Case Report on the Detection and Management of Group A Streptococcal Bacteremia in a Postpartum Patient initially thought to have Sacroiliitis

(3-273) Implementation of Evolocumab in a Patient with Type 2 Diabetes and Underlying Atherosclerotic Cardiovascular Disease

(3-274) Improving Glycemic Control in Older Adults with Type 2 Diabetes Using 4-Day Insulin Patch for Mealtime Insulin Evidenced by Continuous Glucose Monitoring: A Case Report

(3-275) Optimizing Type 2 Diabetes Management in an Ambulatory Care Setting: Efficacy of GLP-1 RA and Basal Insulin Combination

(3-276) Osteoporosis: Know Bones About It

(3-277) Pesticides: From The Farm To The Fork/What Are We Eating?

(3-278) Review of the association between cannabis use and development of type 2 diabetes mellitus

(3-279) Screening for Autoantibodies and Distinguishing Between Type 1 Diabetes and Type 2 Diabetes: The Role of the Pharmacist

(3-280) Semaglutide-Associated Depressive Symptoms: A Case report Highlighting Potential Mental Health Adverse Effects in a patient treated for Obesity

(3-281) Weight Management with Semaglutide in U.S. Adults: Projected Impact on Obesity Prevalence and Heart Failure Risk

(3-282) Quest in compounding new parasite-killing drugs

(3-283) Clinical and operational impact of a pharmacist on a new hospital at home unit in a community hospital setting

(3-284) Inpatient Management of Metformin-induced Lactic Acidosis: A Case Report

(3-285) Torsades De Pointes After Bradycardia During Dexmedetomidine Infusion: A Case Report

(3-286) Navigating the Digital Landscape: Health Literacy in Accessible Online Content for Tirzepatide for Weight Loss

(3-287) Oral Contraceptives and GLP-1 Receptor Agonists

(3-288) Reevaluating Gabapentin Use in Geriatric Population: Risk, Opioids, and the Path Forward

(3-289) Is Ceftriaxone 2 grams Preferred over 1 gram in Patients with Gram-negative Bacteremia?

(3-290) Quality Improvement Initiative to Enhance Nurse Engagement in Antibiotic Stewardship

(3-291) Modified Chronic Mild Stress Paradigm for Assessing Stress-Related Behavioral Alterations in Drosophila Melanogaster

(3-292) Physiological Improvements of Alzheimer’s Disease in First Animal Study Using Novel Compounds

(3-293) Lysine Methyltransferase 2C Mutation Patterns and Hemostasis Pathway Dysregulation are Associated with 5-Fluorouracil Responsiveness in Pancreatic Cancer

(3-294) Shining a Light on Melanoma: Addressing Disparities in Skin of Color for Better Health Outcomes

(3-295) Number of PharmDs Entering Industry Upon Graduation from 2020-2023

(3-296) Impact of a Board-Certified Psychiatric Pharmacist Integrated into a Team-Based Outpatient Psychiatry Clinic

(3-297) Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation

(3-298) Case Report: Diabetic Patient with Sickle Cell Anemia

(3-299) Impact of Glucagon-Like Peptide-1 Receptor Agonists on Weight Changes in Antipsychotic-Treated Patients with Type 2 Diabetes Mellitus

(3-300) Managing Hypoglycemia in a Patient with Elevated A1C and Hypoglycemia Unawareness Using a Continuous Glucose Monitoring System: A Case Report

(3-301) Efficacy and Safety of Paxlovid in Reducing Hospitalizations and Severe Outcomes in High-Risk COVID-19 Patients: A Comprehensive Review

(3-302) Shedding Light on Medication Errors and IV Light-Protection Bags

(3-303) Targeting Glycosylation in Lymphoma: Implications for Drug Therapy

(3-304) Impact of Implementing MRSA Nares Screening on Perioperative Vancomycin Usage in Surgical Patients: A Comparative Pre- and Post-Implementation Study

(3-305) Treating Urinary Tract Infection (UTI) and Treatment-Resistant Depression in the Setting of Multidrug-Resistant Infection and Drug-Drug Interaction: A Focus on Methylphenidate and Linezolid Interaction

(3-306) Evaluating the role of Artificial Intelligence (AI) Tools in Drug Information Retrieval

(3-307) Impact of Semaglutide on Alcohol Consumption : A Case Report of Dual Benefits in Weight Loss and Alcohol Reduction

(3-308) Bridging Psychiatry and Pharmacogenomics: A Comprehensive Review of Pharmacogenomics Implementation in Psychiatry Clinical Practice

(3-309) Atorvastatin-Induced Hypersensitivity Following Dose Escalation in an Adult Female - Case Report

(3-310) Assessing the Impact of Concomitant Use of Sulfonylureas with Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss

(3-311) Literature Review of Secondary Antibody Mediated Response to Non-Toxic Accessory Proteins(NAPs) in Non-Cosmetic Botulinum Toxin A(BoNt-A) Formulations

(3-312) Retrospective Analysis of Oxybutynin Use in Patients Aged 65 and Older Admitted in a Community Hospitals Group

(3-313) Comparative Evaluation of Lupron Depot and Levonorgestrel IUDs in the Management of Endometriosis: A Literature Review

(3-314) Review of Low-Dose Naltrexone for the Treatment of Fibromyalgia

(3-315) Patient Case Report: Optimizing Diabetes Care in the Elderly; Deprescribing Metformin for a 99-year-old with Chronic Kidney Disease

(3-316) Evaluation of Reduced Dose Intravenous Zoledronic Acid for the Prevention of Secondary Fractures in Hospitalized Adult Patients with Renal Impairment

(3-317) Incorporating Pharmacogenomic Data into Pain Management of Ehlers-Danlos Syndrome

(3-318) Use of Anti-Inflammatory Reliever Therapy Versus Albuterol Alone for Managing Exercise-Induced Bronchospasm

(3-319) Evolution of Diversity in Obesity Clinical Trials: A Century of Ethnic and Racial Representation (1924-2024)

(3-320) Pain Management and Harm Reduction Strategies in Hidradenitis Suppurativa

(3-321) Managing Psoriasis in a Patient with Psoriatic Flare by Birth Control Initiation: A Case Report

(3-322) Investigating the Influence of Glycosylation in Disease Progression and Treatment of Multiple Myeloma

(3-323) Risk Assessment for Toxicity in Commonly Used Drugs

(3-324) Exploring the Therapeutic Benefit of Glycosylation Inhibitors in Chronic Myeloid Leukemia

(3-325) Therapeutic Potential of Inhibiting O-Linked Glycosylation in Acute Lymphoid Leukemia

(3-326) Optimizing Biosimilar Policies for Enhanced Healthcare Based on Boston-Area Hospitals

(3-327) Assessing remote blood pressure monitoring for the improvement of health care quality in a community-based organization

(3-328) Investigating Weight Loss Effects of GLP1 RAs and GLP1/GIP RAs at Boston Medical Center’s Endocrine Clinic Utilizing Clinical Pharmacy Follow-up

(3-329) Clinical Outcomes of Potentially Inappropriate Dosing of Direct-Acting Oral Anticoagulants in Older Adults with Atrial Fibrillation

(3-330) A Systematic Review of the Impact of Pharmacy-led Transitions of Care Services at Point of Hospital Discharge

(3-331) Hookah Smoking Amongst Arab Americans: Cultural Attitudes and Challenges in Culturally Competent Healthcare

(3-332) Addressing Medication Access Challenges Due to Shortages: Innovative Solutions from Pharmacy Students

(3-333) U.S. opioid prescribing practices after ICU hospitalizations requiring mechanical ventilation

(3-334) Anti–Xa Monitoring in Patients Receiving Enoxaparin on General Medicine Floors at an Academic Medical Center

(3-335) Evaluation of Tofacitinib and Upadacitinib Inpatient Use at A Large Academic Hospital

(3-336) Early Acute Illness Detection in Community-Dwelling Patients with Dementia

(3-337) Review of Isavuconazole Use at a Tertiary Academic Medical Center

(3-338) Transitioning a Candidemia Patient with Prolonged QTc and Limited Intravenous Central Line Access to Rezafungin

(3-339) The Role of Nutrition in Black Pediatric Patients with Sickle Cell Disease

(3-340) A Systematic Review of Oncology Clinical Trial Enrollment Barriers from a Health Care Provider Perspective

(3-341) Current State of Sleep and Sleep Disorders Education: Survey of Medical Schools

(3-342) Creating Drug Discovery Strategies Through Tragedies

(3-343) Use of emapalumab for the management of refractory hemophagocytic lymphohistiocytosis in a patient with systemic juvenile idiopathic arthritis

(3-344) Characterization of Stress Ulcer Prophylaxis Use After Hospital Discharge in Mechanically Ventilated Intensive Care Unit Adults

(3-345) Is Using Ertapenem Susceptibilities as a Surrogate for Meropenem Susceptibilities Viable?

(3-346) Consumption of grapes reduces biomarkers indicative of cellular damage promoted by UV irradiation of the skin of human volunteers

(3-347) Epigenetic Modulation and Anti-Cancer Properties of Ginger in Neuroblastoma: A Phytochemical Approach to Combat Drug-Resistance

(3-348) Safety of Peripheral Amiodarone: Impact of Excipient Removal

(3-349) Examining the Clinical Demand for PENFAST Scoring in Patients with Recorded Penicillin Allergies: A Descriptive Report

(3-350) Perceived Benefit and Applications of Pharmacogenomics

(3-351) Making a Difference: The Impact of Community Service on Pharmacy Students

(3-352) Comparing Likelihood and Comfort in Deprescribing Antihypertensives Among Pharmacy Students and Preceptors Across Specific Patient Populations

(3-353) Likelihood to Recommend vs Comfort in Deprescribing Proton-Pump Inhibitors Among Third- and Fourth-Year Pharmacy Students and Preceptors

(3-354) Comparison of Time Spent in Internalized Normalized Ratio (INR) Goal Range Between Provider-Dosed and Pharmacist-Dosed Warfarin

(3-355) Evaluation of Therapy for Hepatorenal Syndrome in Non-Intensive Care Unit Patients: A single-center retrospective chart review

(3-356) Retrospective Observational Evaluation of the Rate of Fluid Resuscitation in Acute Pancreatitis

(3-357) Evaluation of Azithromycin Dosing for Patients Admitted with Community Acquired Pneumonia

(3-358) Comparison of Cefdinir versus Cephalexin Failure Rates in the Treatment of Gram-Negative Bacteremia: A single-center retrospective chart review

(3-359) Leveraging Technology to Improve Duration of Antibiotic Therapy in Community Acquired Pneumonia

(3-360) Impact of a Newly Implemented Patient-Controlled Analgesia Protocol on Patients Presenting with Sickle Cell Disease to the Acute Care Setting

(3-361) Prophylactic Dexamethasone Dosing and Incidence of Hypersensitivity Reactions in the Setting of 3-hour Paclitaxel Infusion Chemotherapy Regimens

(3-362) Association Between Maintenance Medication Adherence and the Likelihood of Receiving Antibiotics Among Adults

(3-363) Willingness of Individuals to Talk to Community Pharmacists About Their Sexual Health

(3-364) Evaluating the treatment of community acquired pneumonia in chronic obstructive pulmonary disease patients: a single-center retrospective chart review

(3-365) COMPARE-SBP: Comparative Outcomes in the Management of Prophylactic Antibiotic Regimens for Efficacy in Spontaneous Bacterial Peritonitis: A single-center retrospective chart review

(3-366) Tracking Healthcare Effectiveness Data and Information Set measures for Acute Bronchitis with the Collaboration to Harmonize Antimicrobial Registry Measures.

(3-367) Use of Collaboration to Harmonize Antimicrobial Registry Measure (CHARM) to Track and Assess the Appropriate Treatment for Upper Respiratory Infection HEDIS Measure (URI)

(3-368) Patterns in Initial Dosing of Direct Oral Anticoagulants for Nonvalvular Atrial Fibrillation

(3-369) Assessment of Pharmacist Management of a Direct Oral Anticoagulant (DOAC) Dashboard

(3-370) Evaluation of Diabetic Testing Supplies Dispensing in the Outpatient Pharmacy at a Large Academic Medical Center

(3-371) Influenza and COVID-19 Vaccination Rates in Infants, Children, and Adolescents with Cystic Fibrosis

(3-372) Assessment of Renal Dose Adjustments for Psychotropic Medications in Hospitalized Patients

(3-373) Use and Monitoring of Lithium in Hospitalized Patients